Skip to content

The effects of training with a rehabilitation device(Rebless planar) on upper limb function in stroke patients.

The effects of training with a rehabilitation device(Rebless planar) on upper limb function in stroke patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007661
Enrollment
20
Registered
2022-08-26
Start date
2022-09-19
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Randomized Controlled Trial, 2 Groups 1. Experimental group: Upper limb rehabilitation training with rebless planar 30 minutes 2. Control group: Upper limb rehabilitation training wit

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 19 years and older with stroke 2. Patients with unilateral paralysis(Hemiparesis) 3. Anyone with a Modified Ashworth Scale of 3 or less on the upper arm.

Exclusion criteria

Exclusion criteria: 1. Patient with severe impairment of communication due to cognitive impairment or aphasia. 2. Patient with serious medical conditions that may affect training. 3. Patient with neurological or musculoskeletal disorders that may affect training. 4. Inability to perform other upper limb rehabilitation training 5. Patient participating in a medical device study with the same indication(stroke) as this study, within 30 days after the end of the visit.

Design outcomes

Primary

MeasureTime frame
Motricity Index (MI)_Upper;Fugl-Meyer Assessment of the Upper Extremity (FMA-UE);Modified Barthel Index (MBI);Range of Motion (ROM)

Secondary

MeasureTime frame
Modified Ashworth Scale (MAS)

Countries

Korea, Republic of

Contacts

Public ContactJUNG IL CHUNG

Asan Medical Center

blahman9696@naver.com+82-2-3010-0817

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026